No Data
No Data
Hong Kong stocks fluctuate | Beigene (06160) opened nearly 4%, using the flagship biopharmaceutical production base and clinical research center in the United States.
Beigene (06160) opened nearly 4% higher and rose 3.70% to HKD 96.60 at the time of release with a turnover of HKD 6.5371 million.
BeiGene Ltd. to Announce Mid-Year Financials
BEIGENE: DATE OF AUDIT COMMITTEE MEETING
BeiGene Opens Biologics Facility in New Jersey, US
Express News | Beigene : JP Morgan Raises Target Price to $194 From $186
Beigene (06160.HK) has launched its flagship biopharmaceutical production facility and clinical research center in the USA.
Beigene (06160.HK) (BGNE.US) announced that its new flagship base in the Hopewell Princeton West Innovation Park in New Jersey, USA was officially launched yesterday (the 23rd). Beigene stated that the base covers an area of about 0.17 million square meters, with an investment of $0.8 billion. It took three years to build and has world-class bio-manufacturing capabilities and clinical research centers. It is expected to enhance the company's differentiation competitiveness as a tumor treatment innovation company and provide flexibility for the large-scale production of existing and future innovative drugs. The exclusive commercial biopharmaceutical production area occupies about 3.7.
No Data